The Dysplastic Nevus

References

• Nicholls E. M. Development and elimination of pigmented moles and the anatomical distribution of primary malignant melanoma. Cancer 1973; 32: 191–5
   Google Scholar
• Stegmaier O. C. Natural regression of the pigmented nevus. J Invest Dermatol 1959; 32: 413–20
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr, Elder D E, Guerry D I V, et al. A study of tumor progression. The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147–65
   Google Scholar
• Klaus S. 1984, Personal communication
   Google Scholar
• Moellman G, McGuire J, Lerner A. B. Ultrastructure and biology of pigment cells. Intracellular dynamics and the fine structure of melanocytes with special reference to the effects of MSH and cyclic AMP on microtubules and 10 nm filaments. Yale J Biol Med 1973; 46: 337–60
   Google Scholar
• Elder D E, Greene M H, Bondi E E, Clark W H, Jr. Acquired melanocytic nevi and melanoma. The dysplastic nevus syndrome. Pathology of malignant melanoma, A B Ackerman. Masson, New York 1981; 185–215
   Google Scholar
• Nowell P. C. The clonal evolution of tumor cell populations. Science 1976; 194: 23
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr, Min B H, Kligman L HL. The developmental biology of induced malignant melanomas in guinea pigs and a comparison with other neoplastic systems. Cancer Res 1976; 36: 4079–91
   PubMed Web of Science ®Google Scholar
• Pawlowski A, Haberman H F, Menon I. A. Skin melanoma induced by 7.12 dimethylbenzanthracene in albino guinea pigs and its similarities to skin melanoma of humans. Cancer Res 1980; 40: 3652–60
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B. K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257–66
   PubMed Web of Science ®Google Scholar
• Elwood J M, Gallagher R P, Hill G B, et al. Pigmentation and skin reaction to sun as risk factors for cutaneous malignant melanoma: Western Canada Melanoma Study. Br Med J 1984; 288: 99–102
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B K, Heenan P. J. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 651–56
   PubMedGoogle Scholar
• Beral V, Evans S, Shaw H, Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109: 165–72
   PubMed Web of Science ®Google Scholar
• Reimer R R, Clark W H, Jr, Greene M H, et al. Precursor lesions in familial melanoma—a new genetic pre-neoplastic syndrome. JAMA 1978; 239: 744–6
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr, Reimer R R, Greene M H, et al. Origin of familial melanomas from heritable melanocytic lesions. Arch Dermatol 1978; 114: 732–8
   PubMed Web of Science ®Google Scholar
• Elder D E, Goldman L I, Goldman S C, et al. The dysplastic nevus syndrome—a phenotypic association of cutaneous malignant melanoma. Cancer 1980; 46: 1787–94
   PubMed Web of Science ®Google Scholar
• Elder D E, Greene M H, Guerry D I V, et al. The dysplastic nevus syndrome—our definition. Am J Dermatopathol 1982; 4: 455–60
   Google Scholar
• Greene M H, Clark W H, Jr, Tucker M A, et al. The prospective diagnosis of malignant melanoma in a population at high risk: Hereditary melanoma and the dysplastic nevus syndrome. 1984, submitted
   Google Scholar
• Crutcher W A, Sagebiel R. W. Prevalence of dysplastic nevi in a community practice. Lancet 1984; 1: 729
   Google Scholar
• Rhodes A R, Sober A J, Mihm M C, Fitzpatrick T. B. Possible risk factors for primary cutaneous malignant melanoma. Clin Res 1980; 28: 252
   Google Scholar
• Sheiber A, Milton G W, McCarthy W H, Shaw H. Clinical features, prognosis, and incidence of multiple primary cutaneous malignant melanoma. Aust NZ J Surg 1981; 51: 386
   Google Scholar
• Kraemer K H, Greene M H, Tarone R, et al. Dysplastic nevi and cutaneous melanoma risk. Lancet 1983; 2: 1076
   PubMed Web of Science ®Google Scholar
• Greene M H, Clark W H, Jr, Tucker M A, et al. Clinical recognition of acquired precursors of cutaneous malignant melanoma—a color atlas of the familial dysplastic nevus syndrome. N Engl J Med 1984; 312: 91–7
   Google Scholar
• Rhodes A R, Melski J W, Sober A J, et al. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. J Invest Dermatol 1983; 80: 452–9
   Google Scholar
• Rhodes A R, Harrist T J, Day C L, et al. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983; 9: 563–74
   Google Scholar
• Smith P J, Greene M H, Devlin D A, et al. Abnormal sensitivity to UV-irradiation in cultured skin fibroblasts from patients with hereditary melanoma and the dysplastic nevus syndrome. Int J Cancer 1982; 30: 39–45
   PubMed Web of Science ®Google Scholar
• McGovern V. J. Relationship of melanocytic nevi to melanoma. Melanoma. Histological diagnosis and prognosis. Raven Press, New York 1983; 24–36
   Google Scholar
• Kornstein M J, Brooks J SJ, Elder D. E. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res 1983; 43: 2749–53
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr. 1982, Personal communication
   Google Scholar
• National Institutes of Health, Consensus Development Conference Statement: Precursors to malignant melanoma. JAMA 1984; 251: 1864–6
   PubMed Web of Science ®Google Scholar
• Greene M. H. Dysplastic nevus syndrome. Hospital practice 1984; 19: 91–108
   Web of Science ®Google Scholar
• Greene M H, Clark W H, Jr, Tucker M A, et al. Managing the dysplastic nevus syndrome. Lancet 1984; 1: 166–7
   Google Scholar